Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

By Zhang Jing   Mattison Hayley   Liu Changqin   Ginghina Carmen   Auinger Peggy   McDermott Michael   Stewart Tessandra   Kang Un   Cain Kevin   Shi Min  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 671-682

Springer Publishing Company

Access to resources Recommend Favorite

TOMM40 poly-T Variants and Cerebrospinal Fluid Amyloid Beta Levels in the Elderly

By Pomara Nunzio   Bruno Davide   Nierenberg Jay   Sidtis John   Martiniuk Frank   Mehta Pankaj   Zetterberg Henrik   Blennow Kaj  

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 1124-1128

Springer Publishing Company

Access to resources Recommend Favorite

Amyloid Beta Protein as a Marker or Risk Factor of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 4, Iss. 4, 2007-01 ,pp. : 359-363

Bentham Science Publishers

Access to resources Recommend Favorite

Cerebrospinal Fluid Amyloid 1-42 Levels in the Mild Cognitive Impairment Stage of Alzheimer's Disease

By Maruyama M.   Arai H.   Sugita M.   Tanji H.   Higuchi M.   Okamura N.   Matsui T.   Higuchi S.   Matsushita S.   Yoshida H.   Sasaki H.  

Experimental Neurology, Vol. 172, Iss. 2, 2001-12 ,pp. : 433-436

Elsevier

Access to resources Recommend Favorite

Cerebrospinal fluid TAU protein and amyloid β42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination

By Ivanoiu Adrian   Jm Sindic Christian  

Neurocase, Vol. 11, Iss. 1, 2005-02 ,pp. : 32-39

Routledge Ltd

Access to resources Recommend Favorite